madman
Super Moderator
Background
Acne vulgaris commonly affects adults, adolescents, and preadolescents aged 9 years or older.
Objective
The objective of this study was to provide evidence-based recommendations for themanagement of acne.
Methods
A working group conducted a systematic review and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of evidence and formulating and grading recommendations.
Results
This guideline presents 18 evidence-based recommendations and 5 good practice statements. Strong recommendations are made for benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline. Oral isotretinoin is strongly recommended for acne that is severe, causing psychosocial burden or scarring, or failing standard oral or topical therapy. Conditional recommendations are made for topical clascoterone, salicylic acid, and azelaic acid, as well as for oral minocycline, sarecycline, combined oral contraceptive pills, and spironolactone. Combining topical therapies with multiple mechanisms of action, limiting systemic antibiotic use, combining systemic antibiotics with topical therapies, and adding intralesional corticosteroid injections for larger acne lesions are recommended as good practice statements.
Limitations
Analysis is based on the best available evidence at the time of the systematic review.
Conclusions
These guidelines provide evidence-based recommendations for the management of acne vulgaris. ( J Am Acad Dermatol Redirecting.)
ACNE GRADING AND CLASSIFICATION
MICROBIOLOGICAL AND ENDOCRINE TESTING
ACNE MANAGEMENT
TOPICAL THERAPIES
Topical retinoids
Benzoyl peroxide
Topical antibiotics
Fixed-dose topical combinations
Clascoterone
Salicylic acid
Azelaic acid
Considerations in Topical Therapies
SYSTEMIC ANTIBIOTICS
Doxycycline
Minocycline
Sarecycline
Considerations in Systemic Antibiotics
HORMONAL AGENTS
Combined oral contraceptives
Spironolactone
Intralesional corticosteroid
Considerations in hormonal agents
ISOTRETINOIN
PHYSICAL MODALITIES
COMPLEMENTARY/ALTERNATIVE THERAPIES
DIET
GAPS IN RESEARCH AND STUDY LIMITATIONS
SUMMARY
Analysis of the evidence from this systematic review based on 9 clinical questions resulted in 18 evidence-based recommendations and 5 good practice statements for the treatment of acne. Strong recommendations are made for benzoyl peroxide, topical retinoids, and topical antibiotics, as well as for oral doxycycline. Oral isotretinoin is strongly recommended for acne that is severe, causing psychosocial burden or scarring, or failing standard oral or topical therapy. Conditional recommendations are made for topical clascoterone, salicylic acid, azelaic acid, as well as for oral minocycline,sarecycline, COC pills, and spironolactone. Combining topical therapies with multiple mechanisms of action, limiting systemic antibiotic use, combining systemic antibiotics with topical therapies, and adding intralesional corticosteroid injections for larger acne lesions are recommended as good practice statements (Table III).
Acne vulgaris commonly affects adults, adolescents, and preadolescents aged 9 years or older.
Objective
The objective of this study was to provide evidence-based recommendations for themanagement of acne.
Methods
A working group conducted a systematic review and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of evidence and formulating and grading recommendations.
Results
This guideline presents 18 evidence-based recommendations and 5 good practice statements. Strong recommendations are made for benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline. Oral isotretinoin is strongly recommended for acne that is severe, causing psychosocial burden or scarring, or failing standard oral or topical therapy. Conditional recommendations are made for topical clascoterone, salicylic acid, and azelaic acid, as well as for oral minocycline, sarecycline, combined oral contraceptive pills, and spironolactone. Combining topical therapies with multiple mechanisms of action, limiting systemic antibiotic use, combining systemic antibiotics with topical therapies, and adding intralesional corticosteroid injections for larger acne lesions are recommended as good practice statements.
Limitations
Analysis is based on the best available evidence at the time of the systematic review.
Conclusions
These guidelines provide evidence-based recommendations for the management of acne vulgaris. ( J Am Acad Dermatol Redirecting.)
ACNE GRADING AND CLASSIFICATION
MICROBIOLOGICAL AND ENDOCRINE TESTING
ACNE MANAGEMENT
TOPICAL THERAPIES
Topical retinoids
Benzoyl peroxide
Topical antibiotics
Fixed-dose topical combinations
Clascoterone
Salicylic acid
Azelaic acid
Considerations in Topical Therapies
SYSTEMIC ANTIBIOTICS
Doxycycline
Minocycline
Sarecycline
Considerations in Systemic Antibiotics
HORMONAL AGENTS
Combined oral contraceptives
Spironolactone
Intralesional corticosteroid
Considerations in hormonal agents
ISOTRETINOIN
PHYSICAL MODALITIES
COMPLEMENTARY/ALTERNATIVE THERAPIES
DIET
GAPS IN RESEARCH AND STUDY LIMITATIONS
SUMMARY
Analysis of the evidence from this systematic review based on 9 clinical questions resulted in 18 evidence-based recommendations and 5 good practice statements for the treatment of acne. Strong recommendations are made for benzoyl peroxide, topical retinoids, and topical antibiotics, as well as for oral doxycycline. Oral isotretinoin is strongly recommended for acne that is severe, causing psychosocial burden or scarring, or failing standard oral or topical therapy. Conditional recommendations are made for topical clascoterone, salicylic acid, azelaic acid, as well as for oral minocycline,sarecycline, COC pills, and spironolactone. Combining topical therapies with multiple mechanisms of action, limiting systemic antibiotic use, combining systemic antibiotics with topical therapies, and adding intralesional corticosteroid injections for larger acne lesions are recommended as good practice statements (Table III).